New FDA-Approved Oncology Drugs and Indications, 2011

Published: Thursday, Dec 29, 2011
The FDA approved more new oncology drugs in 2011 than it has in a single year in more than a decade, thanks in part to priority review and streamlined evaluation procedures. While this is good news for patients, oncology and hematology specialists must tackle the challenges posed by integrating new therapies into treatment plans.

The chart below lists the new FDA-approved oncology drugs of 2011 and indications.

Chart Key:

*As of December 1, 2011 | Sources: FDA news releases, Drugs@FDA Website, prescribing information for individual drugs

a Drug approved for the first time

b New indication or formulation for previously approved brand-name drug or agent New FDA-Approved Oncology Drugs and Indications, 2011

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication